Bayer to Invest $150 Million in New Cell Manufacturing Plant in Berkeley

Date Published05/10/2019
Author NameMark Terry
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Bayer Corporation
Parent companyBayer AG
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2019
Year reshoring implemented or to be implemented:2021
Capital investment ($):150
Country(ies) from which reshored:Germany
City reshored to:Berkeley
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredcell culture technology
What domestic positive factors made reshoring more attractive?Automation/technology, Customer responsiveness improvement, Eco-system synergies, Higher productivity, Lead time/Time to market, Manufacturing/engineering joint innovation (R&D)
Find Reshoring Articles